cytarabine has been researched along with amg 232 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L; Hu, L; Li, W; Liao, G; Liu, Z; Ma, L; Wu, P; Yang, D; Zeng, L | 1 |
1 review(s) available for cytarabine and amg 232
| Article | Year |
|---|---|
The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy.
Topics: Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neoplasms; Piperidones; Protein Binding; Proto-Oncogene Proteins c-mdm2; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2018 |